PCV20: Clinical Trials

2 trials of PCV20, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Unknown 1

Follow PCV20: new trials by email Literature Review of PCV20 trials Research Report on PCV20

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
PCV20 - Lymphoma
Phase 4Active not recruitingM.D. Anderson Cancer Center302023-10-062026-09-15
Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years
NVX, PCV20, Placebo - COVID-19, Pneumococcal Infections
Phase 4UnknownMedical University of Vienna2562023-03-012023-03-15

Conditions studied

COVID-19 (1)  ·  Lymphoma (1)  ·  Pneumococcal Infections (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Medical University of Vienna (1)

Countries

United States (1)

Top investigators

Fareed Khawaja, MD (1)

Results publications

PMID 39756693